CanSinoBIO
Tianjin
About CanSinoBIO
Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $288.8M
- Funding stage: IPO
- Last round: Grant (Oct 2023)
- Ticker: hkg:6185
- Website: cansinotech.com
- Phone: +02225616006
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cansinobio-171296 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.